Capital Signal

Invex Therapeutics LTD (ASX: IXC)

Sector: Health Care

Market cap: A$8M (as of 2 Nov 2026)

Biopharmaceuticals.

Data as of 2 Nov 2026.

Recent capital raises

DateTypeAmountPriceDiscountSource
26 Oct 2026Placement$9.1M$0.08—Filing ↗
21 May 2020Placement$26.2M$1.30—Filing ↗

Substantial holders — latest moves

DateHolderMoveHoldingSource
17 Oct 2025Tisia Nominees Pty Ltd <Henderson Family A/C>Entry?% → 5.090%Filing ↗
11 Aug 2025TATTARANGEntry?% → 11.77%Filing ↗
30 July 2024Mr Jason PetersonDecrease11.719% → 10.632%Filing ↗
27 Nov 2023Mr Jason PetersonIncrease10.253% → 11.719%Filing ↗
8 Nov 2023Mr Jason PetersonIncrease6.377% → 10.253%Filing ↗

Director trades — on-market

DateDirectorTradeSource
24 Aug 2023Dr Thomas George DuthyBought 178,738Filing ↗

Cash and runway

MetricValueAs ofSource
CashA$4M30 Sept 2026Filing ↗
Runway8.4 quarters30 Sept 2026Filing ↗

Ask about IXC in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

  • Has IXC raised money in the last year, and at what discount?
  • What was IXC's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading IXC…